[Effect of zilongjin on immunologic function of patients with hepatocarcinoma in perioperative stage].
Li
Qiang
Q
liqiang4016@yahoo.com
Wu
Qiang
Q
Li
Hui-kai
HK
Cui
Yun-long
YL
Gao
Chun-tao
CT
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001402:B-Lymphocytes / Q000276:immunology; D016516:CD4-CD8 Ratio; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000276:immunology* / Q000601:surgery; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D008113:Liver Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D019990:Perioperative Care; D008517:Phytotherapy; D016176:T-Lymphocyte Subsets / Q000276:immunology*
D000276:Adjuvants, Immunologic; D004365:Drugs, Chinese Herbal